14 | Peptides (Polypeptides)IBA
06/2021
-
11/2002 |
8 | IntegrinsIBA
08/2022
-
08/2004 |
7 | arginyl-glycyl-aspartic acidIBA
10/2019
-
11/2002 |
7 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2019
-
11/2002 |
6 | Integrin beta3 (GPIIIa)IBA
12/2009
-
11/2002 |
5 | Proteins (Proteins, Gene)FDA Link
03/2021
-
11/2006 |
5 | ChemokinesIBA
10/2020
-
01/2017 |
5 | cyclic arginine-glycine-aspartic acid peptideIBA
10/2019
-
11/2006 |
4 | Radioisotopes (Radionuclides)IBA
05/2010
-
08/2004 |
3 | AnticoagulantsIBA
01/2023
-
01/2021 |
3 | LigandsIBA
10/2020
-
12/2009 |
3 | Integrin alphaVbeta3IBA
01/2009
-
11/2002 |
3 | aspartic acid glycine arginineIBA
01/2007
-
08/2004 |
2 | CollagenIBA
08/2022
-
01/2021 |
2 | FibrinIBA
01/2022
-
01/2021 |
2 | 3-Tyr-octreotideIBA
06/2012
-
05/2010 |
2 | Chemokine ReceptorsIBA
11/2011
-
11/2011 |
2 | Extracellular Matrix ProteinsIBA
01/2009
-
11/2006 |
2 | Peptide Receptors (Peptide Receptor)IBA
02/2007
-
08/2004 |
1 | VaccinesIBA
03/2023 |
1 | AntioxidantsIBA
01/2023 |
1 | platelet membrane glycoprotein VIIBA
08/2022 |
1 | Focal Adhesion Protein-Tyrosine KinasesIBA
08/2022 |
1 | Epidermal Growth Factor (EGF)IBA
06/2021 |
1 | nonaarginineIBA
06/2021 |
1 | penetratinIBA
06/2021 |
1 | Thromboplastin (Tissue Factor)IBA
01/2021 |
1 | Eptifibatide (Integrilin)FDA Link
01/2021 |
1 | DabigatranFDA Link
01/2021 |
1 | disagreginIBA
01/2021 |
1 | N(4)-oleylcytosine arabinosideIBA
01/2021 |
1 | Vitamin KFDA Link
01/2021 |
1 | Warfarin (Coumadin)FDA LinkGeneric
01/2021 |
1 | CC ChemokinesIBA
10/2020 |
1 | Galectins (Galectin)IBA
01/2020 |
1 | sharpinIBA
10/2019 |
1 | Salivary Proteins and PeptidesIBA
01/2019 |
1 | Carrier Proteins (Binding Protein)IBA
01/2019 |
1 | Chemokine CXCL1IBA
10/2016 |
1 | IsotopesIBA
01/2015 |
1 | matrigelIBA
01/2015 |
1 | salicylhydroxamic acid (SHAM)IBA
12/2014 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
05/2013 |
1 | Leucine EnkephalinIBA
06/2012 |
1 | Bombesin Receptors (Bombesin Receptor)IBA
06/2012 |
1 | BombesinIBA
06/2012 |
1 | Blood Proteins (Serum Proteins)IBA
11/2011 |
1 | plerixaforFDA Link
11/2011 |
1 | AntigensIBA
12/2009 |
1 | AntibodiesIBA
12/2009 |
1 | Fibronectins (Fibronectin)IBA
12/2009 |
1 | Oxygen (Dioxygen)IBA
12/2009 |
1 | TenascinIBA
12/2009 |
1 | Matrix Metalloproteinases (MMPs)IBA
12/2009 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009 |
1 | Arginine (L-Arginine)FDA Link
01/2009 |
1 | Aspartic Acid (Aspartate)FDA Link
01/2009 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
09/2007 |
1 | RadiopharmaceuticalsIBA
09/2007 |
1 | Dendrimers (Dendrons)IBA
03/2007 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2007 |
1 | Lysine (L-Lysine)FDA Link
01/2007 |
1 | VitronectinIBA
11/2006 |
1 | PeptoidsIBA
11/2006 |
1 | PeptidomimeticsIBA
11/2006 |
1 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
11/2002 |
1 | 7- (2- bis(2- hydroxyethyl)aminoethyl)theophylline (G 111)IBA
11/2002 |